Clinico-histopathological study of varicose vein and role of matrix metalloproteinases-1, matrix metalloproteinases-9 and tissue inhibitor of matrix metalloproteinase-1 in varicose vein formation

Indian Journal of Pathology and Microbiology

Volumn 59, Issue 1, 2016, Pages 25-30

  Naik, Bitan ^a   Kumar, Mohan ^a   Khanna, Ajay Kumar ^a   Suman, Pradeep Kumar ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Collagen; elastin fiber; matrix metalloproteinases; smooth muscle; tissue inhibitor of matrix metalloproteinase; varicose vein

Indexed keywords

ANTIBODY; EOSIN; GELATINASE B; HEMATOXYLIN; INTERSTITIAL COLLAGENASE; PARAFFIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TIMP1 PROTEIN, HUMAN;

ADULT; ARTERIOSCLEROSIS; ARTERY INTIMA PROLIFERATION; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; HISTOLOGY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MEDIAL THICKENING; MIDDLE AGED; PATHOGENESIS; PROSPECTIVE STUDY; SCHOOL CHILD; STAINING; VARICOSIS; YOUNG ADULT; AGED; CYTOCHEMISTRY; GENE EXPRESSION PROFILING; INDIA; METABOLISM; MICROSCOPY; PATHOLOGY; PATHOPHYSIOLOGY;

ADULT; AGED; FEMALE; GENE EXPRESSION PROFILING; HISTOCYTOCHEMISTRY; HUMANS; IMMUNOHISTOCHEMISTRY; INDIA; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 9; MICROSCOPY; MIDDLE AGED; PROSPECTIVE STUDIES; TISSUE INHIBITOR OF METALLOPROTEINASE-1; VARICOSE VEINS; YOUNG ADULT;

EID: 84961799059     PISSN: 03774929     EISSN: 09745130     Source Type: Journal    
DOI: 10.4103/0377-4929.178217     Document Type: Article

References (22)

1. Beebe-Dimmer JL, Pfeifer JR, Engle JS, Schottenfeld D. The epidemiology of chronic venous insufficiency and varicose veins. Ann Epidemiol 2005;15:175-84.
2. Raffetto JD, Barros YV, Wells AK, Khalil RA. MMP-2 induced vein relaxation via inhibition of [Ca2+]e-dependent mechanisms of venous smooth muscle contraction. Role of RGD peptides. J Surg Res 2010;159:755-64.
3. Badier-Commander C, Verbeuren T, Lebard C, Michel JB, Jacob MP. Increased TIMP/MMP ratio in varicose veins: A possible explanation for extracellular matrix accumulation. J Pathol 2000;192:105-12.
4. Borden P, Heller RA. Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases. Crit Rev Eukaryot Gene Expr 1997;7:159-78.
5. Evans CJ, Fowkes FG, Ruckley CV, Lee AJ. Prevalence of varicose veins and chronic venous insufficiency in men and women in the general population: Edinburgh Vein Study. J Epidemiol Community Health 1999;53:149-53.
6. Krijnen RM, de Boer EM, Bruynzeel DP. Epidemiology of venous disorders in the general and occupational populations. Epidemiol Rev 1997;19:294-309.
7. Bradbury A, Evans C, Allan P, Lee A, Ruckley CV, Fowkes FG. What are the symptoms of varicose veins? Edinburgh vein study cross sectional population survey. BMJ 1999;318:353-6.
8. Brand FN, Dannenberg AL, Abbott RD, Kannel WB. The epidemiology of varicose veins: The Framingham Study. Am J Prev Med 1988;4:96-101.
9. Sadick NS. Predisposing factors of varicose and telangiectatic leg veins. J Dermatol Surg Oncol 1992;18:883-6.
10. Lim CS, Davies AH. Pathogenesis of primary varicose veins. Br J Surg 2009;96:1231-42.
11. Rabe E, Pannier F. What have we learned from the Bonn Vein study? Phlebolymphology 2006;13:188-94.
12. Carpentier PH, Maricq HR, Biro C, Ponçot-Makinen CO, Franco A. Prevalence, risk factors, and clinical patterns of chronic venous disorders of lower limbs: A population-based study in France. J Vasc Surg 2004;40:650-9.
13. Wali MA, Dewan M, Eid RA. Histopathological changes in the wall of varicose veins. Int Angiol 2003;22:188-93.
14. Travers JP, Brookes CE, Evans J, Baker DM, Kent C, Makin GS, et al. Assessment of wall structure and composition of varicose veins with reference to collagen, elastin and smooth muscle content. Eur J Vasc Endovasc Surg 1996;11:230-7.
15. Woodside KJ, Hu M, Burke A, Murakami M, Pounds LL, Killewich LA, et al. Morphologic characteristics of varicose veins: Possible role of metalloproteinases. J Vasc Surg 2003;38:162-9.
16. Elsharawy MA, Naim MM, Abdelmaguid EM, Al-Mulhim AA. Role of saphenous vein wall in the pathogenesis of primary varicose veins. Interact Cardiovasc Thorac Surg 2007;6:219-24.
17. Gandhi RH, Irizarry E, Nackman GB, Halpern VJ, Mulcare RJ, Tilson MD. Analysis of the connective tissue matrix and proteolytic activity of primary varicose veins. J Vasc Surg 1993;18:814-20.
18. Sansilvestri-Morel P, Fioretti F, Rupin A, Senni K, Fabiani JN, Godeau G, et al. Comparison of extracellular matrix in skin and saphenous veins from patients with varicose veins: Does the skin reflect venous matrix changes? Clin Sci (Lond) 2007;112:229-39.
19. Gillespie DL, Patel A, Fileta B, Chang A, Barnes S, Flagg A, et al. Varicose veins possess greater quantities of MMP-1 than normal veins and demonstrate regional variation in MMP-1 and MMP-13. J Surg Res 2002;106:233-8.
20. Kowalewski R, Sobolewski K, Wolanska M, Gacko M. Matrix metalloproteinases in the vein wall. Int Angiol 2004;23:164-9.
21. Ishikawa Y, Asuwa N, Ishii T, Ito K, Akasaka Y, Masuda T, et al. Collagen alteration in vascular remodeling by hemodynamic factors. Virchows Arch 2000;437:138-48.
22. Kosugi I, Urayama H, Kasashima F, Ohtake H, Watanabe Y. Matrix metalloproteinase-9 and urokinase-type plasminogen activator in varicose veins. Ann Vasc Surg 2003;17:234-8.